Advisor Group Holdings »

Cytomed Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Cytomed Therapeutics (GDTC) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Cytomed Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomed Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomed Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $27 21 1.33

More positions owned by Advisor Group Holdings

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust State Street Spd (SPYM)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr State Street Tec (XLK)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Advisor Group Holdings

Top funds holding Cytomed Therapeutics

Susquehanna International
UBS Group
Advisor Group Holdings

View all funds holding Cytomed Therapeutics